Experiment 182503

Worktypes

PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

TETRAFIBRICIN

Alerts

BIOLOGICAL ACTIVITY REPORTED HAS BEEN PATENTED.DATA INCOMPLETE - DERIVED FROM AN ABSTRACT.

Details

PropertyValue
Pharmacology
FIBRINOGEN BINDING INHIBITION
OrganismStreptomyces neyagawaensis (STREPTOMYCETACEAE)
CitationKAMYAMA,T: SATO,T: WATANABE,J:. (1994). MANUFACTURE OF TETRAFIBRICIN WITH STREPTOMYCES NEYAGAWAENSIS.. ()
Amount utilized
Compound isolated
DiseaseINHIBITED BINDING OF FIBRINOGEN TO GLYCOPROTEIN IIB/IIIA.
Dose amount46.0 NANOMOLS
Number2
Qualitative resultACTIVE
Dose expressionIC50